Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer.
about
Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Phase I Trial of the Combinati ...... ate-Resistant Prostate Cancer.
@en
Phase I Trial of the Combinati ...... ate-Resistant Prostate Cancer.
@nl
type
label
Phase I Trial of the Combinati ...... ate-Resistant Prostate Cancer.
@en
Phase I Trial of the Combinati ...... ate-Resistant Prostate Cancer.
@nl
prefLabel
Phase I Trial of the Combinati ...... ate-Resistant Prostate Cancer.
@en
Phase I Trial of the Combinati ...... ate-Resistant Prostate Cancer.
@nl
P2093
P2860
P1476
Phase I Trial of the Combinati ...... ate-Resistant Prostate Cancer.
@en
P2093
Daryn Smith
Elisabeth Heath
Joseph Fontana
Julie Boerner
Karri Stark
Kimberlee Dobson
Lance Heilbrun
Manish K Thakur
P2860
P304
P356
10.1016/J.CLGC.2018.01.019
P407
P577
2018-02-13T00:00:00Z